Misonix to Report Fiscal 2019 First Quarter Financial Results and Host Conference Call and Webcast on November 8
October 19 2018 - 9:02AM
Misonix, Inc. (NASDAQ: MSON) (“Misonix” or the “Company”), a
provider of minimally invasive therapeutic ultrasonic medical
devices that enhance clinical outcomes, announced today that it
will report its fiscal 2019 first quarter financial results after
the market closes on Thursday, November 8, 2018. The Company will
host a conference call and webcast at 4:30 p.m. ET that day to
review the results. Both the call and webcast are open to the
general public.
To access the conference call, interested
parties may dial 800/458-4148 (domestic) or 323/794-2598
(international) conference ID 9334394. Participants may also listen
to a live webcast of the call through the “Events and
Presentations” section under “Investor Relations” on Misonix’s
website at www.misonix.com. A webcast replay will be available for
30 days following the live event at www.misonix.com.
Please call five minutes in advance to ensure
that you are connected. Questions and answers will be taken only
from participants on the conference call. For the webcast, please
allow 15 minutes to register, download and install any necessary
software.
About Misonix, Inc.Misonix, Inc. (NASDAQ: MSON)
designs, develops, manufactures and markets ultrasonic medical
devices for the precise removal of hard and soft tissue, including
bone removal, wound debridement and ultrasonic aspiration. Misonix
is focused on leveraging its proprietary ultrasonic technology to
become the standard of care in operating rooms and clinics around
the world. Misonix's proprietary ultrasonic medical devices are
used in a growing number of medical procedures, including spine
surgery, neurosurgery, orthopedic surgery, cosmetic surgery,
laparoscopic surgery, and other surgical and medical applications.
At Misonix, Better Matters to us. That is why throughout the
Company’s history, Misonix has maintained its commitment to medical
technology innovation and the development of ultrasonic surgical
products that radically improve patient outcomes. Additional
information is available on the Company's web site at
www.misonix.com.
Contact: |
|
|
Joe DwyerChief Financial
OfficerMisonix, Inc.631-927-9113 |
|
Joseph
Jaffoni, Norberto Aja, Jennifer NeumanJCIR212-835-8500 or
mson@jcir.com |
Misonix (NASDAQ:MSON)
Historical Stock Chart
From Apr 2024 to May 2024
Misonix (NASDAQ:MSON)
Historical Stock Chart
From May 2023 to May 2024
Real-Time news about Misonix Inc (NASDAQ): 0 recent articles
More News Articles